MOLINA HEALTHCARE, INC.
MOLINA HEALTHCARE, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 4,985 | 5,314 | 4,248 | 4,221 | 4,499 | 4,856 | 4,662 | 4,732 | 4,354 | 4,513 | 4,848 | 5,565 | |||||
Marketable Securities Current | 3,930 | 3,937 | 4,008 | 4,226 | 4,310 | 4,438 | 4,325 | 4,482 | 4,347 | 4,424 | 4,259 | 4,111 | |||||
Receivables Net Current | 3,485 | 3,420 | 3,533 | 3,515 | 3,865 | 3,491 | 3,299 | 3,259 | 3,231 | 3,350 | 3,104 | 2,460 | |||||
Prepaid Expense And Other Assets Current | 528 | 655 | 655 | 590 | 438 | 472 | 487 | 408 | 399 | 381 | 331 | 332 | |||||
Assets Current | 12,928 | 13,326 | 12,444 | 12,552 | 13,112 | 13,257 | 12,773 | 12,881 | 12,331 | 12,668 | 12,542 | 12,468 | |||||
Property Plant And Equipment And Finance Lease Rig… | 311 | 300 | 301 | 323 | 305 | 287 | 288 | 306 | 305 | 295 | 270 | 290 | |||||
Intangible Assets Net Including Goodwill | 2,082 | 2,092 | 2,195 | 2,202 | 2,168 | 2,175 | 1,938 | 1,923 | 1,913 | 1,927 | 1,449 | 1,471 | |||||
Restricted Investments Noncurrent | 313 | 312 | 299 | 300 | 291 | 311 | 286 | 289 | 268 | 261 | 261 | 261 | |||||
Deferred Income Tax Assets Net | 229 | 215 | 178 | 179 | 185 | 193 | 207 | 227 | 232 | 228 | 227 | 255 | |||||
Other Assets Noncurrent | 140 | 146 | 147 | 142 | 148 | 163 | 138 | 132 | 136 | 134 | 143 | 125 | |||||
Assets | 16,003 | 16,391 | 15,564 | 15,698 | 16,209 | 16,386 | 15,630 | 15,758 | 15,185 | 15,513 | 14,892 | 14,870 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Liability For Claims And Claims Adjustment Expense | 4,841 | 4,941 | 4,887 | 4,844 | 4,885 | 4,804 | 4,640 | 4,732 | 4,577 | 4,571 | 4,204 | 4,235 | |||||
Accounts Payable And Accrued Liabilities Current | 1,139 | 1,161 | 1,093 | 1,124 | 1,113 | 1,119 | 1,331 | 1,215 | 973 | 1,114 | 1,252 | 1,090 | |||||
Contract With Customer Liability Current | 69 | 401 | 66 | 73 | 57 | 369 | 51 | 364 | 13 | 328 | 418 | 691 | |||||
Liabilities Current | 7,700 | 8,188 | 7,372 | 7,481 | 7,876 | 8,155 | 7,896 | 8,337 | 7,836 | 8,514 | 8,168 | 8,492 | |||||
Long Term Debt Noncurrent | 3,769 | 3,767 | 3,766 | 3,664 | 3,375 | 3,574 | 2,923 | 2,332 | 2,181 | 2,180 | 2,180 | 2,179 | |||||
Finance Lease Liability Noncurrent | 184 | 180 | 184 | 188 | 188 | 192 | 195 | 197 | 203 | 202 | 205 | 199 | |||||
Other Liabilities Noncurrent | 179 | 176 | 173 | 174 | 167 | 155 | 120 | 122 | 122 | 124 | 124 | 121 | |||||
Liabilities | 11,832 | 12,311 | 11,495 | 11,507 | 11,606 | 12,076 | 11,134 | 10,988 | 10,342 | 11,020 | 10,677 | 10,991 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 511 | 471 | 452 | 420 | 454 | 434 | 462 | 453 | 439 | 390 | 410 | 373 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -16 | -7 | 15 | 9 | -10 | -28 | -57 | -9 | -85 | -85 | -82 | -165 | |||||
Retained Earnings Accumulated Deficit | 3,676 | 3,616 | 3,602 | 3,762 | 4,159 | 3,904 | 4,091 | 4,326 | 4,489 | 4,188 | 3,887 | 3,671 | |||||
Stockholders Equity | 4,171 | 4,080 | 4,069 | 4,191 | 4,603 | 4,310 | 4,496 | 4,770 | 4,843 | 4,493 | 4,215 | 3,879 | |||||
Liabilities And Stockholders Equity | 16,003 | 16,391 | 15,564 | 15,698 | 16,209 | 16,386 | 15,630 | 15,758 | 15,185 | 15,513 | 14,892 | 14,870 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | |||||
Shares Outstanding | 52 | 52 | 51 | 51 | 54 | 54 | 56 | 57 | 59 | 59 | 58 | 58 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.89% | 14.64% | 33.55% | - | - | - | - | - | - | - | - | - |
| 2025 | 3.67% | -4.99% | -29.40% | 5.86% | 14.32% | 22.65% | -14.57% | 4.66% | 12.73% | 15.18% | 11.12% | 53.63% |
| 2024 | -1.33% | -12.85% | -16.73% | 7.96% | 10.50% | 1.84% | -9.04% | -6.36% | -11.59% | 19.87% | 26.97% | 16.47% |
| 2023 | - | - | - | 2.24% | 6.59% | 13.53% | 6.61% | 9.53% | 14.81% | -0.43% | -4.45% | -13.86% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.68 | 1.63 | 1.69 | 1.68 | 1.66 | 1.63 | 1.62 | 1.55 | 1.57 | 1.49 | 1.54 | 1.47 | |||||
| Quick Ratio | 1.61 | 1.55 | 1.60 | 1.60 | 1.61 | 1.57 | 1.56 | 1.50 | 1.52 | 1.44 | 1.49 | 1.43 | |||||
| Working Capital | 5.23B | 5.14B | 5.07B | 5.07B | 5.24B | 5.10B | 4.88B | 4.54B | 4.50B | 4.15B | 4.37B | 3.98B | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 2.84 | 3.02 | 2.83 | 2.75 | 2.52 | 2.80 | 2.48 | 2.30 | 2.14 | 2.45 | 2.53 | 2.83 | |||||
| Interest Coverage TTM | 0.97 | 2.12 | 4.07 | 7.60 | 10.73 | 12.79 | 14.47 | 14.80 | 14.08 | 14.30 | 14.43 | 12.50 | |||||
| Debt Ratio | 0.74 | 0.75 | 0.74 | 0.73 | 0.72 | 0.74 | 0.71 | 0.70 | 0.68 | 0.71 | 0.72 | 0.74 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 2.76 | 2.75 | 2.91 | 2.83 | 2.77 | 2.62 | 2.66 | 2.56 | 2.59 | 2.48 | 2.50 | 2.40 | |||||
| Days Sales Outstanding TTM | 30.13 | 27.98 | 27.45 | 27.75 | 29.83 | 29.82 | 28.75 | 26.63 | 27.40 | 29.96 | 28.96 | 25.69 | |||||
| Receivables Turnover TTM | 12.11 | 13.04 | 13.30 | 13.15 | 12.24 | 12.24 | 12.70 | 13.71 | 13.32 | 12.18 | 12.61 | 14.21 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | - | - | 8.92 | - | - | - | 20.43 | - | - | - | 18.78 | - | |||||
| Free Cash Flow Per Share TTM | 5.17 | 4.79 | -12.08 | -11.25 | 7.91 | 9.72 | 9.48 | 1.47 | 2.86 | 14.76 | 27.18 | 35.19 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 12.65% | 12.86% | 13.07% | 13.91% | 14.88% | 15.22% | 15.31% | 16.12% | 15.68% | 15.74% | 15.86% | 15.16% | |||||
| Operating Profit Margin TTM | 0.46% | 0.96% | 1.72% | 2.97% | 3.81% | 4.09% | 4.20% | 4.19% | 4.10% | 4.31% | 4.62% | 4.10% | |||||
| Net Profit Margin TTM | -0.02% | 0.42% | 1.04% | 1.98% | 2.60% | 2.81% | 2.90% | 2.92% | 2.84% | 2.99% | 3.20% | 2.80% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 2.55% | 7.66% | 11.75% | 13.65% | 16.06% | 16.77% | 19.31% | 17.90% | 14.65% | 10.82% | 6.56% | 6.70% | |||||
| Net Income Growth (1Y) | -100.62% | -84.01% | -59.97% | -22.81% | 6.30% | 9.80% | 8.07% | 22.88% | 16.05% | 25.26% | 37.75% | 10.97% | |||||
| EPS Growth (1Y) | -100.64% | -83.40% | -56.48% | -13.73% | 16.15% | 19.97% | 8.63% | 25.03% | 14.08% | 23.14% | 37.99% | 10.97% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -1,698.91 | 36.87 | 19.41 | 11.05 | 14.24 | 15.13 | 14.17 | 17.17 | 16.50 | 22.63 | 19.11 | 20.43 | |||||
| P/B TTM | 2.85 | 1.70 | 2.25 | 2.33 | 3.49 | 4.13 | 3.72 | 4.12 | 3.62 | 5.39 | 4.95 | 4.90 | |||||
| P/S TTM | 0.27 | 0.15 | 0.20 | 0.22 | 0.37 | 0.42 | 0.41 | 0.50 | 0.47 | 0.68 | 0.61 | 0.57 | |||||
| Market Cap | 11.89B | 6.93B | 9.16B | 9.76B | 16.09B | 17.79B | 16.71B | 19.64B | 17.54B | 24.24B | 20.85B | 19.02B | |||||
| Enterprise Value | 10.57B | 5.28B | 8.58B | 9.10B | 14.87B | 16.41B | 14.89B | 17.09B | 15.30B | 21.85B | 18.12B | 15.58B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 269.00M | 249.00M | -638.00M | -574.00M | 427.00M | 525.00M | 544.00M | 84.00M | 169.00M | 871.00M | 1.57B | 2.04B | |||||
| Net Debt | -1.32B | -1.65B | -582.00M | -660.00M | -1.22B | -1.38B | -1.82B | -2.55B | -2.24B | -2.39B | -2.73B | -3.44B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
MOLINA HEALTHCARE, INC. (MOH) — SEC Financial Statements & Analysis
MOLINA HEALTHCARE, INC. (MOH) is a hospital & medical service plans company, incorporated in DE. MOLINA HEALTHCARE, INC. trades on NYSE as: MOH. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MOLINA HEALTHCARE, INC. reported a 2.55% year-over-year revenue growth, a Gross Profit Margin of 12.65% (TTM), a Debt-to-Equity ratio of 2.84x, a Price-to-Sales (P/S) ratio of 0.27x (TTM), a Price-to-Book (P/B) ratio of 2.85x (TTM), at a market cap of $11.89B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 2.55%
- Gross Profit Margin TTM
- 12.65%
- Debt To Equity
- 2.84x
- P/S TTM
- 0.27x
- P/B TTM
- 2.85x
- Market Cap
- $11.89B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MOLINA HEALTHCARE, INC. in?
MOLINA HEALTHCARE, INC. (MOH) operates in the Hospital & Medical Service Plans industry.
What is MOH's market cap?
MOLINA HEALTHCARE, INC. (MOH) has a market capitalization of $11.89B as of 2026-06-30.
What exchange does MOH trade on?
MOLINA HEALTHCARE, INC. (MOH) trades on the NYSE.
Where is MOLINA HEALTHCARE, INC. incorporated?
MOLINA HEALTHCARE, INC. is incorporated in DE.